• Yongjin Han, Yanqiu Li, Zhen Wu, Ying Pei, Saien Lu, Haijie Yu, Yingxian Sun, and Xueyao Zhang.
• Department of Cardiology, First Hospital of China Medical University, Shenyang, Liaoning Province, China.
• Ann. Med. 2024 Dec 1; 56 (1): 24050802405080.

BackgroundHypertension, a worldwide cardiovascular issue, is known to result in significant damage to the left ventricle. Left ventricular hypertrophy refers to an increase in ventricular mass, which is not only the primary independent risk factor for cardiovascular disease onset but also independently related to the risk of death.ObjectivesWe sought to synthesize the existing literature on the occurrence and correlation between hypertension and left ventricular hypertrophy and the progress.MethodsA scoping review was performed based on the methodological framework developed by Arksey & O'Malley. Search in the Pubmed database with no language restrictions, as of September 1, 2024.ResultsOf the 8110 articles retrieved, 110 were finally included. The selected articles were published between 1987 and 2024, with 55.5% (61/110) of the studies in the last five years and 14.5% (16/110) of 2024. The studies covered diagnosis, epidemiology, pathophysiology, prognosis, and treatment of hypertension with left ventricular hypertrophy.ConclusionThe literature reviewed suggests that studies on hypertension combined with left ventricular hypertrophy covered a variety of clinical progress, especially the clinical trial results of some new drugs that may bring great hope for treatment.

16 keywords...

hide…